Krystal Biotech Inc.

NASDAQ: KRYS · Real-Time Price · USD
150.42
0.09 (0.06%)
At close: Aug 15, 2025, 3:59 PM
150.27
-0.10%
After-hours: Aug 15, 2025, 05:36 PM EDT

Krystal Biotech Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
50.24 308.15 -14.43 -22.32
PEG Ratio
0.07 -2.87 -0.19 -0.27
PS Ratio
15.42 66.45 n/a n/a
PB Ratio
4.73 4.33 3.87 2.62
P/FCF Ratio
37.58 -33.49 -13.15 -13.35
P/OCF Ratio
36.29 -37.93 -20.08 -32.39
OCF/S Ratio
0.42 -1.75 n/a n/a
Debt / Equity Ratio
0.01 0.01 0.02 0.01
Quick Ratio
7.02 17.55 13.30 17.18
Current Ratio
7.28 17.76 13.30 17.18
Asset Turnover
0.28 0.06 n/a n/a
Interest Coverage
n/a n/a -27.81 -45.76
Return on Equity
0.09 0.01 -0.27 -0.12
Return on Assets
0.08 0.01 -0.25 -0.11
Return on Invested Capital
0.06 -0.12 -0.27 -0.11
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.93 0.94 n/a n/a
Net Profit Margin
0.31 0.22 n/a n/a
Pretax Profit Margin
0.33 0.25 n/a n/a
Operating Profit Margin
0.23 -2.16 n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.38 0.35 n/a n/a